Proof The Bible Is True

On Sept. 23, 2020, U.S. pharmaceutical and medical devices company Johnson & Johnson, Inc. announced the start of the Phase 3 human clinical trial for its experimental Ad26.COV2.S vaccine for COVID-19. The New Jersey-based company, which is partnering with its subsidiary Janssen Pharmaceutica NV of Belgium on development of the vaccine, is planning to enroll 60,000 volunteers to participate in the trial. Johnson & Johnson recently announced the results of the Phase 1/2a clinical trial for the Ad26.COV2.S vaccine. The double-blind, randomized, placebo-controlled trial included 796 participants divided into two groups consisting of 402 healthy adults 18 to 55 years …read more

Source: Sott health news feed